首页> 外文期刊>Tropical Medicine and International Health: TM and IH >Evaluation of the pyrrole insecticide chlorfenapyr against pyrethroid resistant and susceptible Anopheles funestus (Diptera: Culicidae).
【24h】

Evaluation of the pyrrole insecticide chlorfenapyr against pyrethroid resistant and susceptible Anopheles funestus (Diptera: Culicidae).

机译:吡咯类杀虫剂氯芬那普对拟除虫菊酯抗药性和易感性按蚊的评价(双翅目:葫芦科)。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the pyrrole insecticide chlorfenapyr, which has a novel non-neurotoxic mode of action and is a promising alternative to conventional adulticides, against Anopheles funestus. METHOD: The toxicity of a range of concentrations of chlorfenapyr against pyrethroid resistant and susceptible laboratory reared southern African An. funestus was assessed using standard WHO protocols and analysed using probit analysis. RESULTS: The pyrethroid resistant strain showed consistently higher LD50 and LD95 values compared to the susceptible strain, but these differences were not statistically significant and the magnitude was twofold at most. The LD50 values recorded for An. funestus are approximately three-fold higher than those reported elsewhere for other species of anopheline. CONCLUSIONS: Monooxygenase based pyrethroid resistance in An. funestus does not influence the toxic effect of chlorfenapyr. It is unlikely that such a small decrease in susceptibility of An. funestus to chlorfenapyr relative to other anophelines would have any operational implications. Chlorfenapyr is an important addition to insecticides available for malaria vector control, and could be used as a resistance management tool to either circumvent or slow the development of resistance.
机译:目的:评价吡咯类杀虫剂氯非那普,它具有新颖的非神经毒性作用方式,并且是常规成年杀虫剂对付甲虫按蚊的有希望的替代品。方法:一定浓度的氯芬那比对拟除虫菊酯抗药性和易感实验室饲养的南部非洲安非他命具有毒性。使用标准的WHO方案对真菌进行评估,并使用概率分析进行分析。结果:拟除虫菊酯抗药性菌株比易感菌株始终显示较高的LD50和LD95值,但这些差异在统计学上不显着,且幅度最大为两倍。记录的An的LD50值。真菌比其他地方的按蚊种大约高出三倍。结论:基于单加氧酶的拟除虫菊酯抗药性。真菌不会影响氯芬那普的毒性作用。 An的药敏性这么小的下降是不可能的。相对于其他按蚊,氟氯吡比的真菌将有任何操作意义。氯非那吡是可用于控制疟疾的杀虫剂的重要添加,可以用作抗药性管理工具来规避或减缓抗药性的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号